The role of computed tomography in the management of ovarian tumours of borderline malignancy.
dc.contributor.author | Dobson, M | |
dc.contributor.author | Carrington, Bernadette M | |
dc.contributor.author | Radford, John A | |
dc.contributor.author | Buckley, C H | |
dc.contributor.author | Crowther, Derek | |
dc.date.accessioned | 2010-03-24T14:12:32Z | |
dc.date.available | 2010-03-24T14:12:32Z | |
dc.date.issued | 1997-04 | |
dc.identifier.citation | The role of computed tomography in the management of ovarian tumours of borderline malignancy. 1997, 52 (4):280-3 Clin Radiol | en |
dc.identifier.issn | 0009-9260 | |
dc.identifier.pmid | 9112945 | |
dc.identifier.uri | http://hdl.handle.net/10541/94865 | |
dc.description.abstract | Ovarian tumours of borderline malignancy are a distinct histological and clinical entity diagnosed in up to 15% of patients presenting with an ovarian neoplasm. Compared with frankly malignant tumours, they have a much better prognosis, present at an earlier age, and the majority are stage 1 at diagnosis. This study reviewed 35 patients with ovarian tumours of borderline malignancy referred to the CRC Medical Oncology Unit at The Christie Hospital over a 9-year period and evaluated the role of diagnostic imaging, in particular, the value of postoperative computed tomography (CT). We conclude that in cases of FIGO stage 1 disease where there is complete macroscopic removal of tumour, there is no need for further routine imaging. If chemotherapy is to be given for patients with more advanced disease, a baseline postoperative abdomino-pelvic CT scan and a post-treatment scan are appropriate investigations. | |
dc.language.iso | en | en |
dc.subject | Cancer Staging | en |
dc.subject | Residual Cancer | en |
dc.subject | Ovarian Cancer | en |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Female | |
dc.subject.mesh | Follow-Up Studies | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasm Staging | |
dc.subject.mesh | Neoplasm, Residual | |
dc.subject.mesh | Ovarian Neoplasms | |
dc.subject.mesh | Postoperative Care | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Tomography, X-Ray Computed | |
dc.title | The role of computed tomography in the management of ovarian tumours of borderline malignancy. | en |
dc.type | Article | en |
dc.contributor.department | Department of Diagnostic Radiology, Christie Hospital, Manchester, UK. | en |
dc.identifier.journal | Clinical Radiology | en |
html.description.abstract | Ovarian tumours of borderline malignancy are a distinct histological and clinical entity diagnosed in up to 15% of patients presenting with an ovarian neoplasm. Compared with frankly malignant tumours, they have a much better prognosis, present at an earlier age, and the majority are stage 1 at diagnosis. This study reviewed 35 patients with ovarian tumours of borderline malignancy referred to the CRC Medical Oncology Unit at The Christie Hospital over a 9-year period and evaluated the role of diagnostic imaging, in particular, the value of postoperative computed tomography (CT). We conclude that in cases of FIGO stage 1 disease where there is complete macroscopic removal of tumour, there is no need for further routine imaging. If chemotherapy is to be given for patients with more advanced disease, a baseline postoperative abdomino-pelvic CT scan and a post-treatment scan are appropriate investigations. |